We are live on ! Find out more
BRTX icon

BioRestorative Therapies
BRTX

13 hedge funds and large institutions have $1.42M invested in BioRestorative Therapies in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

40% more capital invested

Capital invested by funds: $1.02M → $1.42M (+$406K)

0.37% more ownership

Funds ownership: 7.93% → 8.29% (+0.37%)

13% less funds holding

Funds holding: 15 → 13 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
5
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$144K
2
Wells Fargo
Wells Fargo
California
+$55.2K
3
UBS Group
UBS Group
Switzerland
+$7.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.79K
5
Osaic Holdings
Osaic Holdings
Arizona
+$957

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$57.9K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$13.4K
3
TRCT
Tower Research Capital (TRC)
New York
-$2.26K
4
SG
StoneX Group
New York
-$326

BRTX Hedge Fund Activity: Q2 2023 in Review

13 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2023, worth a combined $1.42M — up 40% from $1.02M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BRTX and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $144K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $57.9K sold.

  • 13 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2023, down from 15 in Q1 2023.
  • Funds reported $1.42M of BioRestorative Therapies stock for Q2 2023, up 40% quarter-over-quarter.
  • 0 funds opened new BioRestorative Therapies positions in Q2 2023 and 1 closed out, a net change of -1 holder.
  • The largest BioRestorative Therapies buyer in Q2 2023 was Geode Capital Management, an estimated $144K added.
  • The largest BioRestorative Therapies seller in Q2 2023 was Two Sigma Investments, an estimated $57.9K sold.

Based on aggregated 13F filings for Q2 2023.